Antibe Therapeutics Inc. (TSE:ATE – Get Free Report) shares crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.30 and traded as high as C$0.35. Antibe Therapeutics shares last traded at C$0.30, with a volume of 167,044 shares trading hands.
Antibe Therapeutics Stock Performance
The firm has a market capitalization of C$15.64 million, a price-to-earnings ratio of -0.84 and a beta of 0.19. The company has a debt-to-equity ratio of 0.29, a current ratio of 10.06 and a quick ratio of 9.58. The firm’s 50-day simple moving average is C$0.30 and its 200 day simple moving average is C$0.57.
About Antibe Therapeutics
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Further Reading
- Five stocks we like better than Antibe Therapeutics
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- The Most Important Warren Buffett Stock for Investors: His Own
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- Roth IRA Calculator: Calculate Your Potential Returns
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
